| e:Med | Systems Medicine | | Sprecher des nationalen Projektkomitees: Philip Rosenstiel |
| GuideIBD | Molekulare Therapiesteuerung bei Chronisch-entzündlichen Darmerkrankungen | | - Projektleitung: Stefan Schreiber (Philip Rosenstiel)
- Demonstrator in e:Med
|
| IHEC | International Human Epigenome Consortium | | SYSCID und DEEP sind IHEC Projekte |
| iTreat | | | Koordinator/Sprecher: Philip Rosenstiel |
| SysINFLAME | Netzwerk für Systemmedizin chronisch-entzündlicher Erkrankungen (A Systems Approach to Chronic Inflammatory Disease) | | Projektleitung: Stefan Schreiber, Philip Rosenstiel |
| Try-IBD | Multi-dimensional resolution of tryptophan-driven immune-metabolism as a novel pathophysiological principle in inflammatory bowel disease | | Projektleitung: Konrad Aden |
| GRK 1743 | Genes, environment and inflammation | | Sprecher: Andre Franke |
| GRK 1727 | Modulation of Autoimmunity | | Sprecher: Detlef Zillikens |
| GRK 2501 | Translational Evolutionary Research (TransEvo) | | Sprecher: Hinrich Schulenburg |
| IRTG 1911 | Immune regulation of inflammation in allergy and infection | | Sprecher: Prof. Jörg Köhl |
| SFB 877 | Proteolysis as a Regulatory Event in Pathophysiology | | Sprecher: Stefan Rose-John |
| SFB 1182 | Entstehen und Funktionieren von Metaorganismen | | Sprecher: Thomas Bosch |
| SFB 1266 | TransformationsDimensionen – Mensch – Umwelt Wechselwirkungen in Prähistorischen und Archaischen Gesellschaften | | Teilprojektleitung: - F4 Ben Krause-Kyora, Almut Nebel
- Z2 Bernhard Thalheim
|
| SPP 1656 | Intestinale Mikrobiota – Ein mikrobielles Ökosystem an der Grenze zwischen Immunhomöostase und Entzündung | | Teilprojektleiter: John Baines |
| SPP 2002 | Kleine Proteine in Prokaryoten, eine unbekannte Welt | | Sprecherin: Ruth Schmitz-Streit |
| FOR 5042 miTarget | The Microbiome as a Therapeutic Target in Inflammatory Bowel Diseases | | - Sprecher: Andre Franke
- Co-Sprecher: Philip Rosenstiel
|
| 3 TR | 3 TR (Taxonomy, Treatment, Targets and Remission) | | Koordinator: Philip Rosenstiel |
| BioMAP | Biomarkers in Atopic Dermatitis and Psoriasis | | Koordinator: Stefan Weidinger |
| Immuniverse | Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies | | Koordinator: Philip Rosenstiel |
| SYSCID Project unter IHEC | A Systems medicine approach to chronic inflammatory diseases | | Koordinator: Philip Rosenstiel |
| BioNUGUT | Gut Metabotypes as Biomarkers for Nutrition and Health | | Sprecher: Matthias Laudes |
| EASI-Genomics | European Advanced infraStructure for Innovative Genomics | | Prof. Andre Franke |
| EU-STANDS4PM | A European standardization framework for data integration and data-driven in silico models for personalised medicine | - European Commission H2020 Work Programme
- 2019 - 2021
| Prof. Philip Rosenstiel |
| EvoLUNG | Leibniz-WissenschaftsCampus "Evolutionary Medicine of the Lung” | - Leibniz-Gemeinschaft
- 2016 – 2020
| Stellvertr. Sprecher: Hinrich Schulenburg |
| | Rapid, safe suppression of IgE-mediated disease with engineered anti-FceRIa monoclonal antibodies | - National Institutes of Health
| Kooperation Prof. Peipp und Prof. Fred Finkelman (University of Cincinnati) |
| CRU 303 | Pemphigoid Diseases - Molecular Pathways and their Therapeutic Potential | | Sprecher: Professor Dr. Detlef Zillikens |
| TB Sequel | Research Capacity Development Networking | - BMBF and Health Africa Project
- 2016 – 2021
| Leitung Teilprojekt: Prof. Stefan Niemann |
| TRANSLATE NAMSE | Verbesserung der Versorgung von Menschen mit seltenen Erkrankungen | - Innovationsfonds des G-BA
- 2017 - 2020
| |
| DZL | Deutsches Zentrum für Lungenforschung | | |
| DZIF | Deutsches Zentrum für Infektionsforschung | | |
| DZHK | Deutsches Zentrum für Herz-Kreislauf-Forschung e.V. | | |
| ARCN | Airway Research Center Nord | | |
